Lab & COAs
Every batch is third-party tested before release. Find the batch number on your label. Every batch is tested for identity and purity by an independent third-party laboratory before release. Find the batch number on your label and download its certificate.
- 01Synthesized in San Diego, CA
- 02Tested by an independent lab
- 03COA published per batch
- Selank/Semax · 15 mg / 15 mg SLSM1515N0726 · >99.3% PDF SLSM1515N0726
- Semax · 10 mg SEM10N0726 · >99.4% PDF SEM10N0726
- Selank · 10 mg SEL10N0726 · >99.2% PDF SEL10N0726
- BPC-157/TB-500 · 10 mg / 10 mg BT1010N0626 · 99.4% PDF BT1010N0626
- ARA-290 · 20 mg ARA20N0526 · 99.4% PDF ARA20N0526
- NAD+ · 500 mg NAD500N0526 · 99.5% PDF NAD500N0526
- 5-Amino-1MQ · 400 mg 5A1MQ400N0526 · 99.4% PDF 5A1MQ400N0526
- Selank/Semax · 15 mg / 15 mg SLSM1515N0526 · 99.4% PDF SLSM1515N0526
- PT-141/Oxytocin · 10 mg / 5 mg PT105N0526 · 99.1% PDF PT105N0526
- KLOW · 20 mg / 20 mg / 100 mg / 20 mg KLOW202010020N0526 · 99.3% PDF KLOW202010020N0526
- IGF-1 LR3 · 2 mg IGF2N0526 · 99.3% PDF IGF2N0526
- DSIP · 8 mg DSIP8N0526 · 99.2% PDF DSIP8N0526
- BPC-157/TB-500 · 30 mg / 30 mg BPCTB3030N0526 · 99.2% PDF BPCTB3030N0526
- Retatrutide · 20 mg RET20N0426 · >99.3% PDF RET20N0426
- Oxytocin/Methylene Blue · 3 mg / 1 mg OMB0301N0426 · >99.2% PDF OMB0301N0426
- GHK-Cu · 50 mg GHK50N0426 · >99.1% PDF GHK50N0426
- Melanotan II · 30 mg MEL230N0426 · >99.2% PDF MEL230N0426
- Semax · 10 mg SEM10N0326 · >99.1% PDF SEM10N0326
- Epitalon/Thymulin · 50 mg / 10 mg EPTH5010N0326 · >99.3% PDF EPTH5010N0326
- Melanotan II · 15 mg MEL215N0126 · >99.1% PDF MEL215N0126
- DSIP · 8 mg DSIP8N1125 · >99.0% PDF DSIP8N1125
- KPV/Thymosin Alpha-1 · 10 mg / 10 mg TK1010N1125 · >99.0% PDF TK1010N1125
- Tirzepatide · 40 mg TIR40N1125 · >99.0% PDF TIR40N1125
- Retatrutide/Semaglutide · 25 mg / 40 mg RS4025N1125 · >99.0% PDF RS4025N1125
| Product | Form | Strength | Batch | Tested | Purity | COA |
|---|---|---|---|---|---|---|
| Selank/Semax | Nasal | 15 mg / 15 mg | SLSM1515N0726 | 28 Jul 2026 | >99.3% | PDF ↓ SLSM1515N0726 |
| Semax | Nasal | 10 mg | SEM10N0726 | 28 Jul 2026 | >99.4% | PDF ↓ SEM10N0726 |
| Selank | Nasal | 10 mg | SEL10N0726 | 28 Jul 2026 | >99.2% | PDF ↓ SEL10N0726 |
| BPC-157/TB-500 | Nasal | 10 mg / 10 mg | BT1010N0626 | 12 Jun 2026 | 99.4% | PDF ↓ BT1010N0626 |
| ARA-290 | Nasal | 20 mg | ARA20N0526 | 08 Jun 2026 | 99.4% | PDF ↓ ARA20N0526 |
| NAD+ | Nasal | 500 mg | NAD500N0526 | 21 May 2026 | 99.5% | PDF ↓ NAD500N0526 |
| 5-Amino-1MQ | Nasal | 400 mg | 5A1MQ400N0526 | 21 May 2026 | 99.4% | PDF ↓ 5A1MQ400N0526 |
| Selank/Semax | Nasal | 15 mg / 15 mg | SLSM1515N0526 | 21 May 2026 | 99.4% | PDF ↓ SLSM1515N0526 |
| PT-141/Oxytocin | Nasal | 10 mg / 5 mg | PT105N0526 | 21 May 2026 | 99.1% | PDF ↓ PT105N0526 |
| KLOW | Nasal | 20 mg / 20 mg / 100 mg / 20 mg | KLOW202010020N0526 | 21 May 2026 | 99.3% | PDF ↓ KLOW202010020N0526 |
| IGF-1 LR3 | Nasal | 2 mg | IGF2N0526 | 21 May 2026 | 99.3% | PDF ↓ IGF2N0526 |
| DSIP | Nasal | 8 mg | DSIP8N0526 | 21 May 2026 | 99.2% | PDF ↓ DSIP8N0526 |
| BPC-157/TB-500 | Nasal | 30 mg / 30 mg | BPCTB3030N0526 | 21 May 2026 | 99.2% | PDF ↓ BPCTB3030N0526 |
| Retatrutide | Nasal | 20 mg | RET20N0426 | 08 May 2026 | >99.3% | PDF ↓ RET20N0426 |
| Oxytocin/Methylene Blue | Nasal | 3 mg / 1 mg | OMB0301N0426 | 08 May 2026 | >99.2% | PDF ↓ OMB0301N0426 |
| GHK-Cu | Nasal | 50 mg | GHK50N0426 | 08 May 2026 | >99.1% | PDF ↓ GHK50N0426 |
| Melanotan II | Nasal | 30 mg | MEL230N0426 | 08 May 2026 | >99.2% | PDF ↓ MEL230N0426 |
| Semax | Nasal | 10 mg | SEM10N0326 | 20 Mar 2026 | >99.1% | PDF ↓ SEM10N0326 |
| Epitalon/Thymulin | Nasal | 50 mg / 10 mg | EPTH5010N0326 | 20 Mar 2026 | >99.3% | PDF ↓ EPTH5010N0326 |
| Melanotan II | Nasal | 15 mg | MEL215N0126 | 08 Jan 2026 | >99.1% | PDF ↓ MEL215N0126 |
| DSIP | Nasal | 8 mg | DSIP8N1125 | 11 Dec 2025 | >99.0% | PDF ↓ DSIP8N1125 |
| KPV/Thymosin Alpha-1 | Nasal | 10 mg / 10 mg | TK1010N1125 | 24 Nov 2025 | >99.0% | PDF ↓ TK1010N1125 |
| Tirzepatide | Nasal | 40 mg | TIR40N1125 | 24 Nov 2025 | >99.0% | PDF ↓ TIR40N1125 |
| Retatrutide/Semaglutide | Nasal | 25 mg / 40 mg | RS4025N1125 | 24 Nov 2025 | >99.0% | PDF ↓ RS4025N1125 |